Ticagrelor

Last Updated: 09/19/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4994 publications

Indobufen-based dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and network meta-analysis.

Indobufen-based dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and network meta-analysis.

Journal: The Journal of international medical research
Published: September 08, 2026

Ticagrelor-Aspirin With Thrombolysis by Infarct Patterns in Moderate Ischemic Stroke: TAPIS Subgroup Analysis.

Ticagrelor-Aspirin With Thrombolysis by Infarct Patterns in Moderate Ischemic Stroke: TAPIS Subgroup Analysis.

Journal: Stroke
Published: September 03, 2026

Prasugrel versus Ticagrelor in Acute Coronary Syndromes.

Prasugrel versus Ticagrelor in Acute Coronary Syndromes.

Journal: The New England journal of medicine
Published: August 31, 2026

Serial Platelet Function-Guided Antiplatelet Modulation After STEMI: A Randomized Pilot Study.

Serial Platelet Function-Guided Antiplatelet Modulation After STEMI: A Randomized Pilot Study.

Journal: Journal of cardiovascular pharmacology and therapeutics
Published: August 27, 2026

Utility of Pre-operative P2Y12 Levels for Perioperative Bleeding Risk in Isolated Coronary Artery Bypass Surgery.

Utility of Pre-operative P2Y12 Levels for Perioperative Bleeding Risk in Isolated Coronary Artery Bypass Surgery.

Journal: Journal of pharmacy practice
Published: August 16, 2026

Machine Learning Models Integrating CYP2C19 Genotypes for Long-Term Risk Prediction and Personalized Antiplatelet Therapy Selection in Myocardial Infarction.

Machine Learning Models Integrating CYP2C19 Genotypes for Long-Term Risk Prediction and Personalized Antiplatelet Therapy Selection in Myocardial Infarction.

Journal: Journal of cardiovascular pharmacology
Published: August 12, 2026

Ticagrelor versus Clopidogrel in Acute Coronary Syndrome Patients with High Ischemic and Bleeding Risk after Drug-eluting Stent Implantation.

Ticagrelor versus Clopidogrel in Acute Coronary Syndrome Patients with High Ischemic and Bleeding Risk after Drug-eluting Stent Implantation.

Journal: Thrombosis and haemostasis
Published: August 11, 2026

A safety consideration in EP lab: Dramatic prolongation of adenosine induced AV-block in presence of ticagrelor.

A safety consideration in EP lab: Dramatic prolongation of adenosine induced AV-block in presence of ticagrelor.

Journal: HeartRhythm case reports
Published: July 19, 2026

Cutting-Edge Cardiology: Individualizing Antiplatelet Therapy for Optimal Acute Coronary Syndrome Outcomes.

Cutting-Edge Cardiology: Individualizing Antiplatelet Therapy for Optimal Acute Coronary Syndrome Outcomes.

Journal: Cureus
Published: July 16, 2026

Tirofiban-Associated Thrombocytopenia: A Case Report.

Tirofiban-Associated Thrombocytopenia: A Case Report.

Journal: Cureus
Published: July 15, 2026

Correction to "Ticagrelor increases its own potency at the P2Y12 receptor by directly changing the plasma membrane lipid order in platelets".

Correction to "Ticagrelor increases its own potency at the P2Y12 receptor by directly changing the plasma membrane lipid order in platelets".

Journal: British journal of pharmacology
Published: July 13, 2026

Clopidogrel-Induced Hypersensitivity Syndrome Presenting as a Progressive Rash: A Case Report.

Clopidogrel-Induced Hypersensitivity Syndrome Presenting as a Progressive Rash: A Case Report.

Journal: Cureus
Published: July 13, 2026
Showing 1-12 of 4,994

Last Updated: 09/19/2026